Nazartinib S-enantiomer structure
|
Common Name | Nazartinib S-enantiomer | ||
---|---|---|---|---|
CAS Number | 1508256-20-9 | Molecular Weight | 495.016 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C26H31ClN6O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Nazartinib S-enantiomerNazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor. |
Name | EGF816 S-enantiomer |
---|---|
Synonym | More Synonyms |
Description | Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor. |
---|---|
Related Catalog | |
References |
[1]. Gerald Lelais, et al. Compounds and compositions for modulating egfr activity. WO 2013184757A1. |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C26H31ClN6O2 |
Molecular Weight | 495.016 |
Exact Mass | 494.219696 |
LogP | 3.23 |
Index of Refraction | 1.643 |
N-(7-Chloro-1-{(3S)-1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-azepanyl}-1H-benzimidazol-2-yl)-2-methylisonicotinamide |
4-Pyridinecarboxamide, N-[7-chloro-1-[(3S)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl- |
EGF816 (S-enantiomer) |